Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

NCT00463060 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: sunitinib malate (Sutent)
PROCEDURE: radiotherapy

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]